Myriad Genetics | MYGN - Pre Tax Profit


Myriad Genetics reported $4.6M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agilent USD 364M 78M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Bio-Rad Laboratories USD 929.2M 846.3M Dec/2025
Bruker USD 68.2M 140.8M Dec/2025
Danaher USD 1.24B 138M Mar/2026
Illumina USD 157M 220M Mar/2026
J&J USD 8.66B 839M Jun/2026
Mettler Toledo International USD 329.07M 59.84M Dec/2025
Myriad Genetics USD 4.6M 3.4M Dec/2025
OraSure Technologies USD -18.43M 5.14M Dec/2025
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Quest Diagnostics USD 334M 4M Mar/2026
Quidel USD -79.5M 32.9M Mar/2026
Repligen USD 19.11M 2M Dec/2025
Revvity USD 91.56M 35.88M Dec/2025
Standard Biotools USD -14.62M 7.42M Mar/2026
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Veracyte USD 29.97M 10.66M Mar/2026
Waters USD 264.18M 94.06M Dec/2025